These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30476795)

  • 1. Gene expression signature in brain regions exposed to long-term psychosocial stress following acute challenge with cannabinoid drugs.
    Tomas-Roig J; Havemann-Reinecke U
    Psychoneuroendocrinology; 2019 Apr; 102():1-8. PubMed ID: 30476795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated long-term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders.
    Tomas-Roig J; Piscitelli F; Gil V; Quintana E; Ramió-Torrentà LL; Del Río JA; Moore TP; Agbemenyah H; Salinas G; Pommerenke C; Lorenzen S; Beißbarth T; Hoyer-Fender S; Di Marzo V; Havemann-Reinecke U
    CNS Neurosci Ther; 2018 Jun; 24(6):528-538. PubMed ID: 29388323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.
    Brzózka MM; Fischer A; Falkai P; Havemann-Reinecke U
    Behav Brain Res; 2011 Apr; 218(2):280-7. PubMed ID: 21070814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro.
    Szabo B; Müller T; Koch H
    J Neurochem; 1999 Sep; 73(3):1084-9. PubMed ID: 10461898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
    Tomas-Roig J; Wirths O; Salinas-Riester G; Havemann-Reinecke U
    CNS Neurosci Ther; 2016 May; 22(5):387-95. PubMed ID: 26842941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of the cannabinoid receptor agonist WIN55212-2 on dopamine release in rat: an in vivo electrochemical study.
    Wu WC; Wang Y; Chai CY
    Chin J Physiol; 2008 Jun; 51(3):152-9. PubMed ID: 18935910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
    Dhawan J; Deng H; Gatley SJ; Makriyannis A; Akinfeleye T; Bruneus M; Dimaio AA; Gifford AN
    Synapse; 2006 Aug; 60(2):93-101. PubMed ID: 16715483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial stress and cannabinoid drugs affect acetylation of α-tubulin (K40) and gene expression in the prefrontal cortex of adult mice.
    Tomas-Roig J; Ramasamy S; Zbarsky D; Havemann-Reinecke U; Hoyer-Fender S
    PLoS One; 2022; 17(9):e0274352. PubMed ID: 36129937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
    Ganon-Elazar E; Akirav I
    Psychoneuroendocrinology; 2013 Sep; 38(9):1675-87. PubMed ID: 23433741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
    Kathmann M; Bauer U; Schlicker E; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.
    Fanarioti E; Mavrikaki M; Panagis G; Mitsacos A; Nomikos GG; Giompres P
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute D-amphetamine.
    Polissidis A; Chouliara O; Galanopoulos A; Naxakis G; Papahatjis D; Papadopoulou-Daifoti Z; Antoniou K
    Behav Brain Res; 2014 Aug; 270():261-9. PubMed ID: 24867330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzophenanthridine alkaloid, piperonyl butoxide and (S)-methoprene action at the cannabinoid-1 receptor (CB1-receptor) pathway of mouse brain: Interference with [(3)H]CP55940 and [(3)H]SR141716A binding and modification of WIN55212-2-dependent inhibition of synaptosomal l-glutamate release.
    Dhopeshwarkar AS; Nicholson RA
    Eur J Pharmacol; 2014 Jan; 723():431-41. PubMed ID: 24211785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing dopaminergic dynamics in the dorsolateral striatum between adolescent and adult rats: Effect of an acute dose of WIN55212-2.
    Pérez-Valenzuela E; Castillo-Faúndez R; Fuentealba JA
    Brain Res; 2019 Sep; 1719():235-242. PubMed ID: 31181184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease.
    Maneuf YP; Crossman AR; Brotchie JM
    Exp Neurol; 1997 Nov; 148(1):265-70. PubMed ID: 9398468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently.
    Polissidis A; Galanopoulos A; Naxakis G; Papahatjis D; Papadopoulou-Daifoti Z; Antoniou K
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):393-403. PubMed ID: 22391102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 receptor-mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: studies using fast cyclic voltammetry.
    O'Neill C; Evers-Donnelly A; Nicholson D; O'Boyle KM; O'Connor JJ
    J Neurochem; 2009 Feb; 108(3):545-51. PubMed ID: 19187091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study.
    Pistis M; Muntoni AL; Pillolla G; Gessa GL
    Eur J Neurosci; 2002 Jun; 15(11):1795-802. PubMed ID: 12081659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide.
    Landa L; Jurajda M; Sulcova A
    Neuro Endocrinol Lett; 2012; 33(4):446-52. PubMed ID: 22936253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice.
    Dang DK; Shin EJ; Mai AT; Jang CG; Nah SY; Jeong JH; Ledent C; Yamamoto T; Nabeshima T; Onaivi ES; Kim HC
    Free Radic Biol Med; 2017 Jul; 108():204-224. PubMed ID: 28363605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.